WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014185607) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/185607    International Application No.:    PCT/KR2013/010143
Publication Date: 20.11.2014 International Filing Date: 08.11.2013
IPC:
A61K 31/26 (2006.01), A61K 31/155 (2006.01), A61P 11/00 (2006.01)
Applicants: GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION [KR/KR]; 1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do 461-701 (KR).
GIL MEDICAL CENTER [KR/KR]; 21, Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760 (KR)
Inventors: JEONG, Sung Hwan; (KR)
Agent: SON, Min; Hanol Intellectual Property & Law STX R&D Center, 6th Floor 163, YangJaeCheon-ro, Gangnam-gu Seoul 135-855 (KR)
Priority Data:
10-2013-0055347 15.05.2013 KR
Title (EN) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS
(FR) COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER LA FIBROSE PULMONAIRE
(KO) 폐섬유화증 예방 또는 치료용 약학 조성물
Abstract: front page image
(EN)The present invention relates to: a pharmaceutical composition for preventing or treating pulmonary fibrosis, containing isothiocyanate-based compounds and a biguanide preparation as active ingredients; a method for preventing or treating pulmonary fibrosis by using the composition; and a use of the isothiocyanate-based compounds and the biguanide preparation for preparing a preparation for preventing or treating pulmonary fibrosis. The pharmaceutical composition containing the isothiocyanate-based compounds and the biguanide preparations as active ingredients according to the present invention stably prevents and treats pulmonary fibrosis, which is conventionally known to have no specific cure, and thus can be widely used to improve health and welfare through treatment of the pulmonary fibrosis.
(FR)La présente invention concerne une composition pharmaceutique destinée à prévenir ou traiter la fibrose pulmonaire et contenant des composés à base d'isothiocyanate, et une préparation à base de biguanides comme principes actifs ; l'invention concerne également une méthode de prévention ou de traitement de la fibrose pulmonaire au moyen de la composition ; et une utilisation des composés à base d'isothiocyanate et de la préparation à base de biguanides pour obtenir une préparation destinée à prévenir ou traiter la fibrose pulmonaire. La composition pharmaceutique contenant les composés à base d'isothiocyanate et les préparations à base de biguanides comme principes actifs, selon la présente invention, préviennent ou traitent de manière stable la fibrose pulmonaire, qui est traditionnellement connue pour ne pas bénéficier de traitement spécifique, et qui peuvent donc être largement utilisées pour améliorer la santé et le bien-être par le traitement de la fibrose pulmonaire.
(KO)본 발명은 아이소티오시아네이트계 화합물과 바이구아나이드 제제를 유효성분으로 포함하는 폐섬유화증 예방 또는 치료용 약학 조성물, 상기 조성물을 이용하여 폐섬유화증을 예방 또는 치료하는 방법 및 폐섬유화증 예방 또는 치료용 제제를 제조하기 위한 아이소티오시아네이트계 화합물과 바이구아나이드 제제의 용도에 관한 것이다. 본 발명의 아이소티오시아네이트계 화합물과 바이구아나이드 제제를 유효성분으로 포함하는 약학 조성물은 종래에 특별한 치료제가 없는 것으로 알려진 폐섬유화증을 안정적으로 예방 또는 치료할 수 있으므로, 폐섬유화증 치료를 통한 보건복지의 향상에 널리 활용될 수 있을 것이다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)